Outset Medical, Inc.
corporate_fare Company Profile
Outset Medical, Inc. (NASDAQ:OM) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 14 items for OM at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 7/10. Across its 14 most recent items scored 7 or higher, the top rating is 9/10, with 7 rated 8 or above. Recent SEC coverage for OM spans 10-Q, 4, 8-K, 10-K.
Recent high-impact activity:
- Outset Medical 10-Q: Q3 Revenue $33.6M, Loss Narrows, New FDA Form 483 Disclosed
- Outset Medical Posts 78-Cent Quarterly Loss Per Share
- 10% Owner Leonard Braden Michael Buys $870K of Outset Medical Stock
- Outset Medical Reports Q2 Results, Faces Legal & Regulatory Headwinds, Resets Warrant Price
- Outset Medical Posts $18M Q2 Loss, Revenue and Outlook in Focus
Financial Snapshot
Short Interest & Short Volume
8.61 days to coverFINRA reported short interest of 812,767 shares in OM as of the October 30, 2026 settlement, a 12.8% decrease from the prior period — about 8.6 days to cover at its recent average daily volume. On November 20, 2026, 54.6% of OM volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.